Cargando…
Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophrenia
RATIONALE: N-Acetylcysteine (NAC) is currently under investigation as an adjunctive treatment for schizophrenia. The therapeutic potential of NAC may involve modulation of brain glutamate function, but its effects on brain glutamate levels in schizophrenia have not been evaluated. OBJECTIVES: The ai...
Autores principales: | McQueen, Grant, Lally, John, Collier, Tracy, Zelaya, Fernando, Lythgoe, David J., Barker, Gareth J., Stone, James M., McGuire, Philip, MacCabe, James H., Egerton, Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182588/ https://www.ncbi.nlm.nih.gov/pubmed/30141055 http://dx.doi.org/10.1007/s00213-018-4997-2 |
Ejemplares similares
-
O3.7. EFFECT OF N-ACETYLCYSTEINE ON BRAIN GLUTAMATE LEVELS AND RESTING PERFUSION IN SCHIZOPHRENIA
por: McQueen, Grant, et al.
Publicado: (2018) -
Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia
por: McQueen, Grant, et al.
Publicado: (2019) -
T19. GLUTAMATE AND RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Egerton, Alice, et al.
Publicado: (2020) -
Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia
por: McQueen, Grant, et al.
Publicado: (2021) -
S146. EFFECT OF CLOZAPINE ON REGIONAL CEREBRAL BLOOD FLOW IN TREATMENT-RESISTANT SCHIZOPHRENIA
por: Sendt, Kyra-Verena, et al.
Publicado: (2018)